- and Australia,
among others. It is not
licensed in the
United States.
Mencevax (GlaxoSmithKline) and NmVac4-A/C/Y/W-135 (JN-International
Medical Corporation)...
-
medical DNA nanotechnology. In June 2015, the
company acquired Nimenrix and
Mencevax,
meningococcal vaccines, from
GlaxoSmithKline for
around $130 million....
-
protection from
three to five
years (plain
polysaccharide vaccine Menomune,
Mencevax and NmVac-4) to more than
eight years (conjugate
vaccine Menactra). Children...
- that year that it
would sell two
meningitis drugs to Pfizer,
Nimenrix and
Mencevax for
around US$130 million.
Philip Hampton, at that time
chair of the Royal...
-
meningitis Serotype C:
Neisvac C and Meningitec.
Serotypes A/C/W-135/Y:
Mencevax, Nimenrix, Menveo, Menactra.
Serotype B:
Bexsero Typhoid vaccine Salmonella...
